ATARAX Side Effects

7020870-0 | Dyspnoea Exertional
on Sep 20, 2010 Female patient from FRANCE , 20 years of age, was diagnosed with migraine (What is migraine?), hypersensitivity, myotonia and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea exertional. Atarax dosage: 25 Mg, Unk. During the same period patient was treated with LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ), MEXITIL (Unk) (View Mexitil Review and Mexitil Label ), ZOMIG (Unk) (View Zomig Review and Zomig Label ), MAXALT (Unk) (View Maxalt Review and Maxalt Label ). Patient was hospitalized.

7020833-5 | Rash Pustular
Patient was taking Atarax (View Usage). Patient had the following side effects: rash pustular on Sep 20, 2010 from INDIA Additional patient health information: Male patient , 65 years of age, was diagnosed with skin disorder and. Atarax dosage: 25 Mg, 1x/day. During the same period patient was treated with CEFOTAXIME SODIUM (1 G, 2x/day) (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (625 Mg, 2x/day) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CICLOSPORIN (View Ciclosporin Review and Ciclosporin Label ), DEXONA (View Dexona Review and Dexona Label ). Patient was hospitalized.

7020794-9 | Angioedema
Adverse event was reported on Sep 20, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 2 Perfusions) was diagnosed with dysuria, pyrexia and. Location: FRANCE , 48 years of age, After Atarax was administered, patient had the following side effects: angioedema. During the same period patient was treated with URIDOZ (3 G, Single Intake) (View Uridoz Review and Uridoz Label ), PHLOROGLUCINOL (80 Mg, Unk) (View Phloroglucinol Review and Phloroglucinol Label ), BACTRIM DS (1 Unit Single Intake) (View Bactrim Ds Review and Bactrim Ds Label ), PARACETAMOL (1 G, Unk) (View Paracetamol Review and Paracetamol Label ), IBUPROFEN (400 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

7020785-8 | Poisoning
on Sep 20, 2010 Female patient from FRANCE , 14 years of age, was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: poisoning (What is poisoning?). Atarax dosage: 750 Mg, Unk. During the same period patient was treated with SERESTA (300 Mg, Unk) (View Seresta Review and Seresta Label ). Patient was hospitalized.


7018809-7 | Hepatic Enzyme Increased
on Sep 17, 2010 Female patient from SWEDEN , 35 years of age, was diagnosed with depression (What is depression?) and was treated with Atarax (View Usage). Patient had the following side effects: hepatic enzyme increased. Atarax dosage: 10 Mg, As Needed. During the same period patient was treated with MIRTAZAPINE (15 Mg, Unk) (View Mirtazapine Review and Mirtazapine Label ).

7016925-7 | Acidosis, Lung Disorder, Sepsis
Patient was taking Atarax (View Usage). After Atarax was administered, patient had the following side effects: acidosis, lung disorder, sepsis (What is sepsis?) on Sep 17, 2010 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Atarax dosage: 50 Mg Bid + 100 Mg Bid, 2x/day. During the same period patient was treated with REMICADE (5 Mg/kg, Every 6 Weeks) (View Remicade Review and Remicade Label ), NOVATREX ^LEDERLE^ (6/week) (View Novatrex ^lederle^ Review and Novatrex ^lederle^ Label ), CORTANCYL (14 Mg, Unk) (View Cortancyl Review and Cortancyl Label ), SPECIAFOLDINE (5 Mg, 3/week) (View Speciafoldine Review and Speciafoldine Label ), NORSET (30 Mg, Unk) (View Norset Review and Norset Label ). Patient was hospitalized.

7012936-6 | Coma, Electrocardiogram Qrs Complex Prolonged, Suicide Attempt
Adverse event was reported on Sep 10, 2010 by a Male patient taking Atarax (View Usage) (Dosage: 150 Mg, Single (6 Tabl. 25 Mg Max. - Total Amount : 150 Mg)) . Location: GERMANY , 32 years of age, weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: coma, electrocardiogram qrs complex prolonged, suicide attempt. During the same period patient was treated with PREGABALIN (View Pregabalin Review and Pregabalin Label ), DOXEPIN HYDROCHLORIDE (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ), METHADONE (View Methadone Review and Methadone Label ), HEROIN (View Heroin Review and Heroin Label ).

7009597-9 | Coma, Suicide Attempt, Urinary Retention, Vasoplegia Syndrome
on Sep 13, 2010 Female patient from FRANCE , 28 years of age, was treated with Atarax (View Usage). Patient had the following side effects: coma, suicide attempt, urinary retention, vasoplegia syndrome. Atarax dosage: 50 Mg, Unk. During the same period patient was treated with ALPRAZOLAM (15 Mg, Single) (View Alprazolam Review and Alprazolam Label ), EQUANIL (51 G, Single) (View Equanil Review and Equanil Label ), DIPIPERON (800 Mg, Single) (View Dipiperon Review and Dipiperon Label ), ESCITALOPRAM OXALATE (10 Mg, Morning) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), TERCIAN (20 Mg Daily) (View Tercian Review and Tercian Label ).

7007397-7 | Coma, Electrocardiogram Qrs Complex Prolonged, Suicide Attempt
on Sep 10, 2010 Male patient from GERMANY , 32 years of age, weighting 167.6 lb, was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: coma, electrocardiogram qrs complex prolonged, suicide attempt. Atarax dosage: 150 Mg, Single (6 Tabl. 25 Mg Max. - Total Amount : 150 Mg). During the same period patient was treated with PREGABALIN (6300 Mg, Single) (View Pregabalin Review and Pregabalin Label ), DOXEPIN HYDROCHLORIDE (3650 Mg, Single) (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ), METHADONE (View Methadone Review and Methadone Label ), HEROIN (View Heroin Review and Heroin Label ).

7006112-0 | Rash Pustular
Patient was taking Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: rash pustular on Sep 10, 2010 from INDIA Additional patient health information: Male patient , 65 years of age, was diagnosed with skin disorder and. Atarax dosage: 25 Mg, 1x/day. During the same period patient was treated with CEFOTAXIME SODIUM (1 G, 2x/day) (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (625 Mg, 2x/day) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CICLOSPORIN (View Ciclosporin Review and Ciclosporin Label ), DEXONA (View Dexona Review and Dexona Label ). Patient was hospitalized.

7003274-6 | Dementia, Fall, Hypoglycaemia, Urinary Tract Infection
Adverse event was reported on Sep 09, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, Unk) was diagnosed with sleep disorder (What is sleep disorder?), dementia alzheimer's type, hypothyroidism and. Location: FRANCE , 84 years of age, Patient had the following side effects: dementia (What is dementia?), fall (What is fall?), hypoglycaemia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with HALDOL (10 Gtt, Unk) (View Haldol Review and Haldol Label ), TRIMEPRAZINE TAB (40 Gtt, Unk) (View Trimeprazine Tab Review and Trimeprazine Tab Label ), MEMANTINE HYDROCHLORIDE (20 Mg, Unk) (View Memantine Hydrochloride Review and Memantine Hydrochloride Label ), DIAZEPAM (10 Mg, Unk) (View Diazepam Review and Diazepam Label ), MEPRONIZINE (Unk) (View Mepronizine Review and Mepronizine Label ), ARICEPT (5 Mg, Unk) (View Aricept Review and Aricept Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Unk) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LEVOTHYROXINE SODIUM (15 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized and became disabled.

7002069-7 | Agitation, Aphasia, Disorientation, Eye Disorder
on Sep 17, 2010 Female patient from UNITED STATES , 87 years of age, weighting 110.0 lb, was diagnosed with rash pruritic and was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: agitation, aphasia (What is aphasia?), disorientation, eye disorder. Atarax dosage: 1 Or 2 At Bedtime Oral. Patient was hospitalized.

6988544-X | Depressed Level Of Consciousness, Respiratory Depression
on Sep 10, 2010 Female patient from JAPAN , child 12 years of age, was diagnosed with restlessness, nausea (What is nausea?) and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, respiratory depression. Atarax dosage: 25 Mg, Single. During the same period patient was treated with PRIMPERAN TAB (10 Mg, Single) (View Primperan Tab Review and Primperan Tab Label ).

6985395-7 | Urinary Retention
Patient was taking Atarax (View Usage). Patient had the following side effects: urinary retention on Sep 01, 2010 from SWEDEN Additional patient health information: Female patient , 85 years of age, . Atarax dosage: 25 Mg, Unk. During the same period patient was treated with DOLOXENE (50 Mg, Unk) (View Doloxene Review and Doloxene Label ), KEPPRA (View Keppra Review and Keppra Label ), ALVEDON (View Alvedon Review and Alvedon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), KALCIPOS D (View Kalcipos-d Review and Kalcipos-d Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARBOMER (View Carbomer Review and Carbomer Label ).

6978845-3 | Anaphylactic Reaction, Skin Test
Adverse event was reported on Aug 30, 2010 by a Female patient taking Atarax (View Usage) (Dosage: Unk) . Location: FRANCE , 87 years of age, After Atarax was administered, patient had the following side effects: anaphylactic reaction, skin test. During the same period patient was treated with OFLOCET (200mg/40ml) (View Oflocet Review and Oflocet Label ), TROPICAMIDE (Unk) (View Tropicamide Review and Tropicamide Label ), NEO SYNEPHRINE OPHTHALMICS (Unk) (View Neo-synephrine Ophthalmics Review and Neo-synephrine Ophthalmics Label ), AMOXICILLIN (Unk) (View Amoxicillin Review and Amoxicillin Label ).

6978379-6 | Urinary Incontinence
on Sep 01, 2010 Male patient from FRANCE , 30 years of age, was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: urinary incontinence (What is urinary incontinence?). Atarax dosage: 75 Mg, Daily.

6978378-4 | Dysarthria, Speech Disorder
on Sep 01, 2010 Female patient from FRANCE , 29 years of age, was treated with Atarax (View Usage). Patient had the following side effects: dysarthria, speech disorder. Atarax dosage: 300 Mg, Daily. During the same period patient was treated with NORSET (2 Units, Unk) (View Norset Review and Norset Label ), EFFEXOR (375 Mg, Unk) (View Effexor Review and Effexor Label ), SERTRALINE (Unk) (View Sertraline Review and Sertraline Label ), LEXOMIL (Dosage Was 3/4 Of Tablet Per Day) (View Lexomil Review and Lexomil Label ), IMOVANE (Dosage Was 1 To 2 Tablets At Night) (View Imovane Review and Imovane Label ), DIAZEPAM (5 Mg, 1x/day) (View Diazepam Review and Diazepam Label ).

6976541-X | Hepatic Enzyme Increased
Patient was taking Atarax (View Usage). After Atarax was administered, patient had the following side effects: hepatic enzyme increased on Aug 30, 2010 from SWEDEN Additional patient health information: Female patient , 35 years of age, was diagnosed with depression (What is depression?) and. Atarax dosage: 10 Mg, As Needed. During the same period patient was treated with MIRTAZAPINE (15 Mg, Unk) (View Mirtazapine Review and Mirtazapine Label ).

6972654-7 | Urinary Retention
Adverse event was reported on Aug 30, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, Unk) . Location: SWEDEN , 85 years of age, Patient experienced the following unwanted or unexpected effects: urinary retention. During the same period patient was treated with DOLOXENE (50 Mg, Unk) (View Doloxene Review and Doloxene Label ), KEPPRA (View Keppra Review and Keppra Label ), ALVEDON (View Alvedon Review and Alvedon Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), KALCIPOS D (View Kalcipos-d Review and Kalcipos-d Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CARBOMER (View Carbomer Review and Carbomer Label ).

6972616-X | Dyspnoea, Lip Swelling, Rash
on Aug 30, 2010 Male patient from SWEDEN , 50 years of age, was diagnosed with urticaria and was treated with Atarax (View Usage). Patient had the following side effects: dyspnoea, lip swelling, rash (What is rash?). Atarax dosage: 50 Mg, Daily. During the same period patient was treated with BETAPRED (View Betapred Review and Betapred Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), AZELAIC ACID (View Azelaic Acid Review and Azelaic Acid Label ), EMOVAT (View Emovat Review and Emovat Label ).

6967587-6 | Coma, Electrocardiogram Qrs Complex Prolonged, Suicide Attempt
on Aug 26, 2010 Male patient from GERMANY , 32 years of age, weighting 167.6 lb, was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: coma, electrocardiogram qrs complex prolonged, suicide attempt. Atarax dosage: 150 Mg, Single. During the same period patient was treated with PREGABALIN (6300 Mg, Single) (View Pregabalin Review and Pregabalin Label ), DOXEPIN HYDROCHLORIDE (3650 Mg, Single) (View Doxepin Hydrochloride Review and Doxepin Hydrochloride Label ).

6939953-6 | Lip Swelling
Patient was taking Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: lip swelling on Aug 13, 2010 from SWEDEN Additional patient health information: Female patient , 67 years of age, . Atarax dosage: Unk. Patient was hospitalized.

6938395-7 | Blood Creatine Phosphokinase Increased, Confusional State, Convulsion, Dysarthria, Mental Disorder, Pyrexia, Tremor
Adverse event was reported on Aug 13, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, Daily) was diagnosed with anxiety (What is anxiety?), sleep disorder (What is sleep disorder?), hypothyroidism and. Location: FRANCE , 72 years of age, weighting 121.3 lb, Patient had the following side effects: blood creatine phosphokinase increased, confusional state, convulsion, dysarthria, mental disorder, pyrexia, tremor. During the same period patient was treated with LEVOTHYROXINE SODIUM (37 Ug, Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LYSANXIA (10 Mg, 3x/day) (View Lysanxia Review and Lysanxia Label ), STILNOX (1 Df, 1x/day) (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

6936328-0 | Aggression, Agitation, Altered State Of Consciousness, Cytolytic Hepatitis, Dehydration, Dyskinesia, Hyperthermia, Renal Failure Acute, Rhabdomyolysis
on Aug 11, 2010 Male patient from FRANCE , child 9 years of age, was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: aggression, agitation, altered state of consciousness, cytolytic hepatitis, dehydration, dyskinesia, hyperthermia, renal failure acute, rhabdomyolysis. Atarax dosage: Unk. During the same period patient was treated with ARTANE (Unk) (View Artane Review and Artane Label ), RISPERDAL (Unk) (View Risperdal Review and Risperdal Label ), METHYLPHENIDATE (Unk) (View Methylphenidate Review and Methylphenidate Label ), NEULEPTIL (Unk) (View Neuleptil Review and Neuleptil Label ), TERCIAN (Unk) (View Tercian Review and Tercian Label ).

6925418-4 | Dyspnoea Exertional
on Aug 04, 2010 Female patient from FRANCE , 20 years of age, was diagnosed with migraine (What is migraine?), hypersensitivity, myotonia and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea exertional. Atarax dosage: 25 Mg, Unk. During the same period patient was treated with LOPRESSOR (Unk) (View Lopressor Review and Lopressor Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ), MEXITIL (Unk) (View Mexitil Review and Mexitil Label ), ZOMIG (Unk) (View Zomig Review and Zomig Label ), MAXALT (Unk) (View Maxalt Review and Maxalt Label ). Patient was hospitalized.

6925157-X | Blood Potassium Increased
Patient was taking Atarax (View Usage). Patient had the following side effects: blood potassium increased on Aug 09, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, weighting 116.8 lb, was diagnosed with senile pruritus, eczema (What is eczema?) and. Atarax dosage: 25 Mg, 1x/day. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE (1 Df, 2x/day) (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ).

6922991-7 | Hepatitis Fulminant
Adverse event was reported on Aug 02, 2010 by a Male patient taking Atarax (View Usage) (Dosage: 50 Mg, Daily) was diagnosed with depression (What is depression?) and. Location: FRANCE , 87 years of age, After Atarax was administered, patient had the following side effects: hepatitis fulminant. During the same period patient was treated with DIFFU K (600 Mg, Daily) (View Diffu K Review and Diffu K Label ), CYMBALTA (60 Mg, Daily) (View Cymbalta Review and Cymbalta Label ), ANAFRANIL (25 Mg, Daily) (View Anafranil Review and Anafranil Label ), LORAZEPAM (1.25 Mg, Daily) (View Lorazepam Review and Lorazepam Label ), KARDEGIC (75 Mg, Daily) (View Kardegic Review and Kardegic Label ), DIAMICRON (30 Mg, Daily) (View Diamicron Review and Diamicron Label ), LANSOPRAZOLE (15 Mg, Daily) (View Lansoprazole Review and Lansoprazole Label ), FUROSEMIDE (40 Mg, Daily) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6922980-2 | Lichenoid Keratosis, Prurigo, Toxic Skin Eruption
on Aug 04, 2010 Male patient from FRANCE , 92 years of age, was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis, prurigo, toxic skin eruption. Atarax dosage: Unk. During the same period patient was treated with SPIRONOLACTONE (Unk) (View Spironolactone Review and Spironolactone Label ), ESCITALOPRAM (Unk) (View Escitalopram Review and Escitalopram Label ), AERIUS (Unk) (View Aerius Review and Aerius Label ), XATRAL (Unk) (View Xatral Review and Xatral Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6918631-3 | Confusional State, Vitamin D Deficiency
on Jul 30, 2010 Male patient from FRANCE , 83 years of age, was diagnosed with psychomotor hyperactivity and was treated with Atarax (View Usage). Patient had the following side effects: confusional state, vitamin d deficiency. Atarax dosage: 50 Mg, At Night. During the same period patient was treated with RISPERDAL (Unk) (View Risperdal Review and Risperdal Label ), EQUANIL (250mg Three Units Per Day And 400mg At Night) (View Equanil Review and Equanil Label ), NEXIUM (20 Mg, In The Morning) (View Nexium Review and Nexium Label ), CANDESARTAN CILEXETIL (8 Mg, In The Morning) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), EMOLLIENTS AND PROTECTIVES (View Emollients And Protectives Review and Emollients And Protectives Label ), IMMUGRIP (Unk) (View Immugrip Review and Immugrip Label ), PNEUMOCOCCAL VACCINE (Dosage Was In Nov2009 And Dec2009) (View Pneumococcal Vaccine Review and Pneumococcal Vaccine Label ). Patient was hospitalized.

6916766-2 | Neutropenia, Thrombocytopenia
Patient was taking Atarax (View Usage). After Atarax was administered, patient had the following side effects: neutropenia, thrombocytopenia on Jul 20, 2010 from FRANCE Additional patient health information: Female patient , 56 years of age, weighting 238.1 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Atarax dosage: 50 Mg, Daily. During the same period patient was treated with RISPERIDONE (37.5mg/2ml Powder And Injectable Solution Slow Release, 1 Unit Each 2 Weeks.) (View Risperidone Review and Risperidone Label ), AMLOR (10 Mg, 1x/day, 1 Capsule/day) (View Amlor Review and Amlor Label ), ALDACTONE (50 Mg, 1x/day, 1 Tablet/day) (View Aldactone Review and Aldactone Label ), VITAMIN B1 TAB (Dosage Was 1 Tablet) (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), AOTAL (Dosage Was 2 Tablets Twice A Day) (View Aotal Review and Aotal Label ), ESCITALOPRAM OXALATE (10 Mg, Unk) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

6916762-5 | Coma, Convulsion, Electrocardiogram Qt Prolonged, Overdose
Adverse event was reported on Jul 29, 2010 by a Male patient taking Atarax (View Usage) (Dosage: 4.5 G, Single Intake) . Location: FRANCE , 15 years of age, Patient experienced the following unwanted or unexpected effects: coma, convulsion, electrocardiogram qt prolonged, overdose. During the same period patient was treated with DEPAKOTE (4 G, 25 Mg, Single Intake) (View Depakote Review and Depakote Label ), PARACETAMOL (8 G, Single Intake) (View Paracetamol Review and Paracetamol Label ).

6908468-3 | Cytolytic Hepatitis
on Jul 26, 2010 Female patient from FRANCE , 33 years of age, was treated with Atarax (View Usage). Patient had the following side effects: cytolytic hepatitis. Atarax dosage: Unk. During the same period patient was treated with METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), OFLOCET (Unk) (View Oflocet Review and Oflocet Label ), LOVENOX (4000 Iu, Udaily) (View Lovenox Review and Lovenox Label ), SPASFON (Unk) (View Spasfon Review and Spasfon Label ), CORTANCYL (60 Mg, Unk) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6895793-8 | Respiratory Arrest
on Jul 26, 2010 Female patient from JAPAN , child 12 years of age, was diagnosed with restlessness and was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: respiratory arrest. Atarax dosage: 25 Mg, Single. During the same period patient was treated with PRIMPERAN TAB (10 Mg, Single) (View Primperan Tab Review and Primperan Tab Label ).

6895767-7 | Pancreatitis Acute
Patient was taking Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Jul 20, 2010 from FRANCE Additional patient health information: Female patient , 48 years of age, . Atarax dosage: 25 Mg, 3x/day. During the same period patient was treated with VALIUM (10 Mg, 2x/day) (View Valium Review and Valium Label ), CYMBALTA (60 Mg, 2x/day) (View Cymbalta Review and Cymbalta Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), IMOVANE (1 Df, 1x/day) (View Imovane Review and Imovane Label ), LANTUS (Unk) (View Lantus Review and Lantus Label ), NOCTRAN 10 (10 Mg, Daily) (View Noctran 10 Review and Noctran 10 Label ), NEXIUM (40 Mg, Daily) (View Nexium Review and Nexium Label ), CREON (7500 Iu, Daily) (View Creon Review and Creon Label ). Patient was hospitalized.

6895331-X | Blood Potassium Increased
Adverse event was reported on Jul 21, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with senile pruritus, eczema (What is eczema?) and. Location: JAPAN , 84 years of age, weighting 116.8 lb, Patient had the following side effects: blood potassium increased. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE (1 Df, 2x/day) (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ).

6878289-9 | Cytolytic Hepatitis
on Jul 20, 2010 Female patient from FRANCE , 33 years of age, was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: cytolytic hepatitis. Atarax dosage: Unk. During the same period patient was treated with METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), OFLOCET (Unk) (View Oflocet Review and Oflocet Label ), LOVENOX (4000 Iu, Udaily) (View Lovenox Review and Lovenox Label ), SPASFON (Unk) (View Spasfon Review and Spasfon Label ), CORTANCYL (60 Mg, Unk) (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6878223-1 | Blood Potassium Increased
on Jul 21, 2010 Female patient from JAPAN , 84 years of age, weighting 116.8 lb, was diagnosed with senile pruritus, eczema (What is eczema?) and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased. Atarax dosage: 25 Mg, 1x/day. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE (1 Df, 2x/day) (View Calcium Polystyrene Sulfonate Review and Calcium Polystyrene Sulfonate Label ).

6872094-5 | Confusional State, Hyperparathyroidism
Patient was taking Atarax (View Usage). Patient had the following side effects: confusional state, hyperparathyroidism on Jul 13, 2010 from GERMANY Additional patient health information: Male patient , 76 years of age, was diagnosed with pruritus and. Atarax dosage: 25 Mg, Unk.

6856582-3 | Neutropenia, Thrombocytopenia
Adverse event was reported on Jul 07, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, 2x/day) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: FRANCE , 56 years of age, After Atarax was administered, patient had the following side effects: neutropenia, thrombocytopenia. During the same period patient was treated with RISPERIDONE (37.5mg/2ml Powder And Injectable Solution Slow Release, 1 Unit Each 2 Weeks.) (View Risperidone Review and Risperidone Label ), AMLOR (10 Mg, 1x/day, 1 Capsule/day) (View Amlor Review and Amlor Label ), ALDACTONE (50 Mg, 1x/day, 1 Tablet/day) (View Aldactone Review and Aldactone Label ), VITAMIN B1 TAB (Dosage Was 1 Tablet) (View Vitamin B1 Tab Review and Vitamin B1 Tab Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), AOTAL (Dosage Was 2 Tablets Twice A Day) (View Aotal Review and Aotal Label ), ESCITALOPRAM OXALATE (Dosage Was 10 Mg) (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ). Patient was hospitalized.

6847815-8 | Idiopathic Thrombocytopenic Purpura, Suicide Attempt
on Jul 06, 2010 Female patient from FRANCE , 24 years of age, was diagnosed with anxiety (What is anxiety?), headache (What is headache?), contraception and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: idiopathic thrombocytopenic purpura, suicide attempt. Atarax dosage: 1 Df, Alternate Day. During the same period patient was treated with FLUOXETINE (20 Mg, Unk) (View Fluoxetine Review and Fluoxetine Label ), DOLIPRANE (1 G, Unk) (View Doliprane Review and Doliprane Label ), NUVARING (1 Df, Monthly) (View Nuvaring Review and Nuvaring Label ). Patient was hospitalized.

6803365-6 | Haematuria, Haemolysis, Lymphopenia, Oliguria, Renal Failure Acute
on Jun 16, 2010 Female patient from FRANCE , 46 years of age, was diagnosed with anaesthesia, enema administration, preoperative care and was treated with Atarax (View Usage). Patient had the following side effects: haematuria, haemolysis, lymphopenia, oliguria, renal failure acute. Atarax dosage: 75 Mg, 1x/day. During the same period patient was treated with PROPOFOL (Unk) (View Propofol Review and Propofol Label ), ATRACURIUM (Unk) (View Atracurium Review and Atracurium Label ), SEVORANE (Unk) (View Sevorane Review and Sevorane Label ), NORMACOL (Unk) (View Normacol Review and Normacol Label ), POVIDONE IODINE (Unk) (View Povidone-iodine Review and Povidone-iodine Label ), BETADINE (Unk) (View Betadine Review and Betadine Label ), DROPERIDOL (Unk) (View Droperidol Review and Droperidol Label ), AUGMENTIN '125' (2 G, 2g/200mg) (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

6801191-5 | Radial Nerve Palsy
Patient was taking Atarax (View Usage). After Atarax was administered, patient had the following side effects: radial nerve palsy on Jun 22, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, weighting 103.6 lb, was diagnosed with anxiety disorder, lymphoma (What is lymphoma?) and. Atarax dosage: 25 Mg, 1x/day. During the same period patient was treated with ONCOVIN (1.8 Mg, 1x/day) (View Oncovin Review and Oncovin Label ), RITUXAN (500 Mg, 1x/day) (View Rituxan Review and Rituxan Label ), ENDOXAN (1000 Mg, 1x/day) (View Endoxan Review and Endoxan Label ), ADRIACIN (65 Mg, 1x/day) (View Adriacin Review and Adriacin Label ), PREDONINE (100 Mg, 1x/day) (View Predonine Review and Predonine Label ).

6783184-X | Eosinophilia, Rash Morbilliform
Adverse event was reported on Jun 11, 2010 by a Female patient taking Atarax (View Usage) (Dosage: 25 Mg, Unk) was diagnosed with pruritus, hypersensitivity, bronchitis (What is bronchitis?) and. Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, rash morbilliform. During the same period patient was treated with ZYRTEC (10 Mg, 2x/day) (View Zyrtec Review and Zyrtec Label ), ROCEPHIN (1 G, Unk) (View Rocephin Review and Rocephin Label ), OFLOXACIN (200 Mg, Unk) (View Ofloxacin Review and Ofloxacin Label ), DIFFU K (View Diffu K Review and Diffu K Label ), CALCIPARINE (5000 Iu, 2x/day) (View Calciparine Review and Calciparine Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), SOTALOL (View Sotalol Review and Sotalol Label ). Patient was hospitalized.

6781962-4 | Leukopenia
on Jun 10, 2010 Male patient from FRANCE , 72 years of age, was treated with Atarax (View Usage). Patient had the following side effects: leukopenia. Atarax dosage: 25 Mg, Daily. During the same period patient was treated with NEXIUM (80 Mg, Daily) (View Nexium Review and Nexium Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PETHIDINE (View Pethidine Review and Pethidine Label ), BACTRIM (View Bactrim Review and Bactrim Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), LASIX (View Lasix Review and Lasix Label ), ISOPTIN (View Isoptin Review and Isoptin Label ), INNOHEP (View Innohep Review and Innohep Label ). Patient was hospitalized.

6779013-0 | Confusional State, Hyperparathyroidism
on Jun 09, 2010 Male patient from GERMANY , 76 years of age, was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: confusional state, hyperparathyroidism. Atarax dosage: .

6769637-9 | Skin Necrosis
Patient was taking Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: skin necrosis on Jun 09, 2010 from JAPAN Additional patient health information: Male patient , 45 years of age, was diagnosed with sedation and. Atarax dosage: 25 Mg. During the same period patient was treated with SOSEGON (15 Mg, 1x/day) (View Sosegon Review and Sosegon Label ).

6768596-2 | Completed Suicide
Adverse event was reported on Jun 02, 2010 by a Female patient taking Atarax (View Usage) (Dosage: Unk) . Location: FRANCE , 21 years of age, Patient had the following side effects: completed suicide.

6768536-6 | Myositis
on Jun 03, 2010 Female patient from SOUTH AFRICA , 39 years of age, was diagnosed with depression (What is depression?) and was treated with Atarax (View Usage). After Atarax was administered, patient had the following side effects: myositis (What is myositis?). Atarax dosage: . During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), WELLBUTRIN (300 Mg, Daily) (View Wellbutrin Review and Wellbutrin Label ), TOPAMAX (50 Mg, 2x/day) (View Topamax Review and Topamax Label ).

6764353-1 | Pyrexia, Tachycardia, Tremor
on May 31, 2010 Female patient from FRANCE , 46 years of age, was diagnosed with bipolar i disorder and was treated with Atarax (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, tachycardia, tremor. Atarax dosage: 50 Mg, Daily. During the same period patient was treated with XANAX (0.5 Mg, 3x/day) (View Xanax Review and Xanax Label ), LEPTICUR (60 Mg, Daily) (View Lepticur Review and Lepticur Label ), CYMBALTA (60 Mg, Unk) (View Cymbalta Review and Cymbalta Label ), LOXAPAC (50mg/2ml) (View Loxapac Review and Loxapac Label ), CLOPIXOL (DECANOATE) (300 Mg, 1x/14 Weeks) (View Clopixol (decanoate) Review and Clopixol (decanoate) Label ), SULFARLEM (View Sulfarlem Review and Sulfarlem Label ), DEPAMIDE (300 Mg, 2x/day) (View Depamide Review and Depamide Label ). Patient was hospitalized.

6763890-3 | Blood Potassium Increased
Patient was taking Atarax (View Usage). Patient had the following side effects: blood potassium increased on Jun 04, 2010 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with pruritus and. Atarax dosage: 75 Mg Daily.